Citi Pharma receives approval to acquire Pakheim International
Both outlets reported that Citi Pharma Limited received regulatory approval to acquire Pakheim International Pharma (Private) Limited. The Business Recorder mentioned the filing to the Pakistan Stock Exchange, while ProPakistani focused on the approval of the entire shareholding acquisition. Both framed the development as a regulatory milestone for the company.
Summary generated by HarZaviya from the headlines and excerpts of the 2 outlets below. Each outlet's own headline is listed under it.
Same story from 2 outlets
Each outlet's own headline, most recent first — read any at its source.
-
CCP allows Citi Pharma to acquire Pakheim
KARACHI: The Competition Commission of Pakistan (CCP) has authorised Citi Pharma Limited’s proposed acquisition of 100 percent shareholding in Pakheim International Pharma (Private) Limited, determining that the transaction does not raise competition concerns. In a material information notice submitted to the Pakistan Stock Exchange (PSX) on October 16, Citi Pharma said it had received the CCP’...
-
Citi Pharma Gets CCP Approval to Acquire Pakheim International Pharma
Citi Pharma Limited has received regulatory approval to acquire the entire shareholding of Pakheim International Pharma (Private) Limited, bringing the… Read More
3 articles from 2 outlets, 19 Oct–20 Oct 2026. Headlines and links belong to their outlets — HarZaviya links out and never copies article text. What does % identical mean?